Vol 4, No 2 (June 19, 2013): Journal of Gastrointestinal Oncology

Original Articles

A comparison of three treatment strategies for locally advanced and borderline resectable pancreatic cancer
Shane Lloyd, Bryan W. Chang
Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis
Jonah Cohen, Eduardo Hariton, Darshan Kothari, German A. Pihan, Simon C. Robson
Neoadjuvant chemoradiotherapy for esophageal/ gastroesophageal carcinoma
Timothy A. Platz, Steven J. Nurkin, Mei Ka Fong, Adrienne Groman, Leayn Flaherty, Usha Malhotra, Charles M. LeVea, Sai Yendamuri, Graham W. Warren, Hector R. Nava, Kilian S. May
Clinical applications of gene expression in colorectal cancer
Elrasheid A.H. Kheirelseid, Nicola Miller, Kah Hoong Chang, Mary Nugent, Michael J. Kerin
Differential lymph node retrieval in rectal cancer: associated factors and effect on survival
Cedrek McFadden, Brian McKinley, Brian Greenwell, Kaylee Knuckolls, Patrick Culumovic, David Schammel, Christine Schammel, Steven D Trocha
Recent advances and significance of intra-arterial infusion chemotherapy in non-resectable colorectal liver metastasis
Atsushi Nanashima, Hiroaki Takeshita, Takafumi Abo, Kazuo Tou, Kenji Tanaka, Daisuke Fukuda, Masaki Kunizaki, Shigekazu Hidaka, Terumitsu Sawai
Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy
Ju-Li Koh, Winston Liauw, Terence Chua, David L. Morris
Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy
Melanie Demes, Stefanie Scheil-Bertram, Holger Bartsch, Annette Fisseler-Eckhoff
Can only chemoradiotherapy and chemotherapy treatment be applied to patients with rectal cancer who could not be operated?
Dogan Koca, Ilhan Oztop, Ugur Yilmaz
Treatment outcome of gastric extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type in the Hong Kong Chinese population: a single centre experience
Ka-Shing Cheng, Yiu-Kay Chan, Yat-Wah Yeung
The aspartate aminotransferase to platelet ratio before chemotherapy predicts adverse events for FOLFOX and XELOX regimens including bevacizumab as the first-line therapy for stage IV, recurrent and metastatic colorectal cancer
Sumito Sato, Hiroshi Nakano, Yasuo Ishida, Takehito Otsubo